- WORLD VIEW
Caution with AI-generated content in biomedicine
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Medicine 29, 532 (2023)
doi: https://doi.org/10.1038/d41591-023-00014-w
Competing interests
A.Z. is the founder and CEO of Insilico Medicine, a clinical-stage biotechnology company developing generative artificial intelligence and robotic platforms for drug discovery; holds multiple granted patents in generative biology and generative chemistry; and is an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.